Shattuck Labs, Inc. (NASDAQ:STTK) Q4 2022 Earnings Conference Call February 23, 2023 4:45 PM ET
Company Participants
Conor Richardson - Vice President, Investor Relations
Taylor Schreiber - Chief Executive Officer and Scientific Co-Founder
Lini Pandite - Chief Medical Officer
Andrew Neill - Chief Financial Officer
Conference Call Participants
Jonathan Miller - Evercore ISI
Marc Frahm - Cowen
Yigal Nochomovitz - Citi
Zhiqiang Shu - Berenberg
Operator
Good afternoon, ladies and gentlemen. Welcome to the Shattuck Labs Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. And I will now turn the call over to your host, Mr. Conor Richardson, Vice President of Investor Relations at Shattuck Labs. Conor, please go ahead.
Conor Richardson
Thank you, operator. Good afternoon, everyone and welcome to the Shattuck Labs conference call regarding our fourth quarter and full year 2022 financial results and recent business updates. The press release reporting our financial results was issued after market close this afternoon and can be found on the Investor Relations section of our website shattucklabs.com.
During this afternoon’s call, the Shattuck leadership team will provide a business overview of the fourth quarter and full year of 2022, including clinical development updates for SL-172154, our lead program and SL-279252. We will refer to these as 154 and 252 throughout today’s earnings call.
Speaking on today’s call will be our Chief Executive Officer and Scientific Co-Founder, Dr. Taylor Schreiber, who will review our pipeline progress and upcoming key milestones, followed by our Chief Medical Officer, Dr. Lini Pandite, who will provide an update on our ongoing clinical activities. And then our Chief Financial Officer, Mr. Andrew Neill will review our fourth quarter and full-year 2022 financial results and financial guidance. Dr. Schreiber will return to make some closing remarks and we will then open the call for questions.
Before we begin, I would like to remind you that today’s webcast contains forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements represent management’s judgment as of today and may involve certain risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by these statements. For more information on these risks and uncertainties, please refer to our most recent Annual Report on Form 10-K for the year ended December 31, 2022 and our other filings with the SEC, which are available from the SEC’s website or on our corporate website shattucklabs.com. Any forward-looking statements represent our views as of today, February 23, 2023.